Page 1314 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 5

125. Garcia DA, Baglin TP, Weitz JI, Samama MM; American College 140. Gunther KE, Conway G, Leibach L, Crowther MA. Low-dose
of Chest Physicians. Parenteral anticoagulants: Antithrombotic oral vitamin K is safe and effective for outpatient manage-
Therapy and Prevention of Thrombosis, 9th ed: American ment of patients with an INR>10. Thromb Res. 2004;113(3-4):
College of Chest Physicians Evidence-Based Clinical Practice 205-209.
Guidelines. Chest. February 2012;141(2 suppl):e24S-e43S. 141. Baumann Kreuziger LM, Morton CT, Dries DJ. New antico-
126. Landefeld CS, Cook EF, Flatley M, Weisberg M, Goldman L. agulants: a concise review. J Trauma Acute Care Surg. October
Identification and preliminary validation of predictors of major 2012;73(4):983-992.
bleeding in hospitalized patients starting anticoagulant therapy. 142. Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective
Am J Med. April 1987;82(4):703-713. validation of the International Society of Thrombosis and
127. Juergens CP, Semsarian C, Keech AC, Beller EM, Harris PJ. Haemostasis scoring system for disseminated intravascular
Hemorrhagic complications of intravenous heparin use. Am J coagulation. Crit Care Med. December 2004;32(12):2416-2421.
Cardiol. July 15, 1997;80(2):150-154. 143. Cartin-Ceba R, Kojicic M, Li G, et al. Epidemiology of critical
128. Byrne M, Zumberg M. Intentional low-molecular-weight hepa- care syndromes, organ failures, and life-support interventions
rin overdose: a case report and review. Blood Coagul Fibrinolysis. in a suburban US community. Chest. December 2011;140(6):
December 2012;23(8):772-774. 1447-1455.
129. Firozvi K, Deveras RA, Kessler CM. Reversal of low-molecular- 144. Toh CH, Downey C. Performance and prognostic importance
weight heparin-induced bleeding in patients with pre-existing of a new clinical and laboratory scoring system for identify-
hypercoagulable states with human recombinant activated fac- ing non-overt disseminated intravascular coagulation. Blood
tor VII concentrate. Am J Hematol. August 2006;81(8):582-589. Coagul Fibrinolysis. January 2005;16(1):69-74.
130. Penning-van Beest FJ, van Meegen E, Rosendaal FR, Stricker 145. Taylor FB Jr, Toh CH, Hoots WK, et al. Towards definition,
BH. Characteristics of anticoagulant therapy and comorbid- clinical and laboratory criteria, and a scoring system for dissem-
ity related to overanticoagulation. Thromb Haemost. August inated intravascular coagulation. Thromb Haemost. November
2001;86(2):569-574. 2001;86(5):1327-1330.
131. van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet 146. Burwick RM, Feinberg BB. Eculizumab for the treatment
E. Bleeding complications in oral anticoagulant therapy. An of preeclampsia/HELLP syndrome. Placenta. February
analysis of risk factors. Arch Intern Med. July 12, 1993;153(13): 2013;34(2):201-203.
1557-1562. 147. Salmon JE, Heuser C, Triebwasser M, et al. Mutations in
132. Gage BF, Yan Y, Milligan PE, et al. Clinical classification complement regulatory proteins predispose to preeclampsia:
schemes for predicting hemorrhage: results from the National a genetic analysis of the PROMISSE cohort. PLoS Medicine.
Registry of Atrial Fibrillation (NRAF). Am Heart J. March March 2011;8(3):e1001013.
2006;151(3):713-719. 148. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman
133. Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin SA. Maternal morbidity and mortality in 442 pregnancies with
H, Ezra D. Comparison of oral vs intravenous phytonadione hemolysis, elevated liver enzymes, and low platelets (HELLP syn-
(vitamin K1) in patients with excessive anticoagulation: a drome). Am J Obstet Gynecol. October 1993;169(4):1000-1006.
prospective randomized controlled study. Arch Intern Med. 149. Sibai BM. Diagnosis, controversies, and management of the
November 10, 2003;163(20):2469-2473. syndrome of hemolysis, elevated liver enzymes, and low platelet
134. Dentali F, Ageno W, Crowther M. Treatment of coumarin- count. Obstet Gynecol. May 2004;103(5, pt 1):981-991.
associated coagulopathy: a systematic review and proposed 150. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M.
treatment algorithms. J Thromb Haemost. September 2006;4(9): Early coagulopathy predicts mortality in trauma. J Trauma. July
1853-1863. 2003;55(1):39-44.
135. Contreras M, Ala FA, Greaves M, et al. Guidelines for the use
of fresh frozen plasma. British Committee for Standards in 151. Cothren CC, Moore EE, Hedegaard HB, Meng K. Epidemiology
Haematology, Working Party of the Blood Transfusion Task of urban trauma deaths: a comprehensive reassessment 10 years
Force. Transfus Med. March 1992;2(1):57-63. later. World J Surg. July 2007;31(7):1507-1511.
136. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and manage- 152. Reynolds BR, Forsythe RM, Harbrecht BG, et al. Hypothermia
ment of the vitamin K antagonists: American College of Chest in massive transfusion: have we been paying enough attention
Physicians Evidence-Based Clinical Practice Guidelines (8th to it? J Trauma Acute Care Surg. August 2012;73(2):486-491.
Edition). Chest. June 2008;133(6 suppl):160S-198S. 153. Hardy JF, De Moerloose P, Samama M; Groupe d’interet en
137. Chong CT, Lew TW, Kuperan P, Tan JJ, Tan HL, Kwek TK. Hemostase Périopératoire. Massive transfusion and coagulopa-
Rapid reversal of coagulopathy in warfarin-related intracra- thy: pathophysiology and implications for clinical management.
nial haemorrhages with prothrombin complex concentrates. Can J Anaesth. April 2004;51(4):293-310.
Anaesthes Intensive Care. May 2010;38(3):474-480. 154. Spahn DR, Bouillon B, Cerny V, et al. Management of bleed-
138. Dentali F, Marchesi C, Pierfranceschi MG, et al. Safety of pro- ing and coagulopathy following major trauma: an updated
thrombin complex concentrates for rapid anticoagulation rever- European guideline. Crit care. April 19, 2013;17(2):R76.
sal of vitamin K antagonists. A meta-analysis. Thromb Haemost. 155. Sihler KC, Napolitano LM. Massive transfusion: new insights.
September 2011;106(3):429-438. Chest. December 2009;136(6):1654-1667.
139. Patel RJ, Witt DM, Saseen JJ, Tillman DJ, Wilkinson DS. 156. Nascimento B, Callum J, Tien H, et al. Effect of a fixed-ratio
Randomized, placebo-controlled trial of oral phytonadione (1:1:1) transfusion protocol versus laboratory-results-guided
for excessive anticoagulation. Pharmacotherapy. October transfusion in patients with severe trauma: a randomized feasi-
2000;20(10):1159-1166. bility trial. CMAJ. September 3, 2013;185(12):E583-E589.

Section07-O-ref.indd 5 1/21/2015 11:26:48 AM